Mount Vernon Associates Inc Bristol Myers Squibb CO Transaction History
Mount Vernon Associates Inc
- $121 Million
- Q3 2024
A detailed history of Mount Vernon Associates Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mount Vernon Associates Inc holds 30,879 shares of BMY stock, worth $1.71 Million. This represents 1.32% of its overall portfolio holdings.
Number of Shares
30,879
Previous 29,779
3.69%
Holding current value
$1.71 Million
Previous $1.24 Million
29.1%
% of portfolio
1.32%
Previous 1.1%
Shares
25 transactions
Others Institutions Holding BMY
# of Institutions
2,457Shares Held
1.5BCall Options Held
29.6MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$10.3 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.77 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$5.06 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.13 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.26 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $118B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...